Mostrar el registro sencillo del ítem
SARS-CoV-2 breakthrough infections: incidence and risk factors in a large European multicentric cohort of health workers
| dc.contributor.author | Porru, S. | |
| dc.contributor.author | Monaco, M. G. L. | |
| dc.contributor.author | Spiteri, G. | |
| dc.contributor.author | Tardón García, Adonina | |
| dc.contributor.author | Rodríguez Suárez, Marta María | |
| dc.contributor.author | Fernández Tardón, Guillermo | |
| dc.contributor.author | Jimeno Demuth, Francisco José | |
| dc.contributor.author | Castro Delgado, Rafael | |
| dc.contributor.author | Iglesias Cabo, Tania | |
| dc.date.accessioned | 2023-04-25T10:12:18Z | |
| dc.date.available | 2023-04-25T10:12:18Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Vaccines, 10(8) (2022); doi:10.3390/vaccines10081193 | |
| dc.identifier.issn | 2076-393X | |
| dc.identifier.uri | http://hdl.handle.net/10651/67476 | |
| dc.description.sponsorship | European Commission, H2020 [101016167]; Regional Health Authority (Azienda Zero), Veneto Region, Italy; Health Research Institute of Asturias (ISPA), Spain | |
| dc.description.statementofresponsibility | Porru S, Monaco MGL, Spiteri G, Carta A, Pezzani MD, Lippi G, Gibellini D, Tacconelli E, Dalla Vecchia I, Sala E, Sansone E, De Palma G, Bonfanti C, Lombardo M, Terlenghi L, Pira E, Mansour I, Coggiola M, Ciocan C, Godono A, Tardon A, Rodriguez-Suarez MM, Fernandez-Tardon G, Jimeno-Demuth FJ, Castro-Delgado RV, Iglesias Cabo T, Scapellato ML, Liviero F, Moretto A, Mason P, Pavanello S, Volpin A, Vimercati L, Tafuri S, De Maria L, Sponselli S, Stefanizzi P, Caputi A, Gobba F, Modenese A, Casolari L, Garavini D, D'Elia C, Mariani S, Filon FL, Cegolon L, Negro C, Ronchese F, Rui F, De Michieli P, Murgia N, Dell'Omo M, Muzi G, Fiordi T, Gambelunghe A, Folletti I, Mates D, Calota VC, Neamtu A, Perseca O, Staicu CA, Voinoiu A, Fabiánová E, Bérešová J, Adamčáková ZK, Nedela R, Lesňáková A, Holčíková J, Boffetta P, Abedini M, Ditano G, Asafo SS, Visci G, Violante FS, Zunarelli C, Verlato G | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Vaccines | |
| dc.rights | © 2022 Los autores | |
| dc.rights | CC Reconocimiento 4.0 Internacional | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137389944&doi=10.3390%2fvaccines10081193&partnerID=40&md5=92134c88ff3eec50745591e7a0a167d2 | |
| dc.title | SARS-CoV-2 breakthrough infections: incidence and risk factors in a large European multicentric cohort of health workers | |
| dc.type | journal article | |
| dc.identifier.doi | 10.3390/vaccines10081193 | |
| dc.relation.projectID | info:eu‐repo/grantAgreement/EC/H2020/101016167 | |
| dc.relation.publisherversion | http://dx.doi.org/10.3390/vaccines10081193 | |
| dc.rights.accessRights | open access | |
| dc.type.hasVersion | VoR |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [34664]
-
Investigaciones y Documentos OpenAIRE [7577]
Publicaciones resultado de proyectos financiados con fondos públicos -
Medicina [897]
Este ítem está sujeto a una licencia Creative Commons